Advanced in Obesity

John M. Wentworth

99 Commercial Road, 
Melbourne, VIC, AU 
Advanced in Obesity
99 Commercial Road, 
Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

John Wentworth practices in Melbourne, Australia. Mr. Wentworth is rated as an Advanced expert by MediFind in the treatment of Obesity. His top areas of expertise are Type 1 Diabetes (T1D), Obesity, Type 2 Diabetes (T2D), Neurohypophyseal Diabetes Insipidus, and Endoscopy.

His clinical research consists of co-authoring 103 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 23 articles in the study of Obesity.

Gender
Male

Locations

99 Commercial Road, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 2, Randomised, Placebo Controlled Study Investigating the Efficacy of Baricitinib in New Onset Type 1 Diabetes Mellitus
A Phase 2, Randomised, Placebo Controlled Study Investigating the Efficacy of Baricitinib in New Onset Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: December 03, 2024
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Hydroxychloroquine for Prevention of Abnormal Glucose Tolerance and Diabetes in Individuals At-risk for Type 1 Diabetes Mellitus (T1D)
Enrollment Status: Terminated
Publish Date: April 09, 2024
Intervention Type: Drug
Study Drug: Hydroxychloroquine
Study Phase: Phase 2
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Exploring Immunologic Effects of Oral Insulin in Relatives at Risk for Type 1
Enrollment Status: Completed
Publish Date: July 27, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

103 Total Publications

Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study.
Longitudinal Continuous Glucose Monitoring Study in Young Children With Presymptomatic Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) At-Risk Cohort Study.
Journal: Diabetes care
Published: April 07, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wentworth's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile